Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib.
Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Shibata H, Aoki T, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Kaibori M, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: tani j. Cancer Med. 2023 Jan;12(1):325-334. doi: 10.1002/cam4.4854. Epub 2022 Jun 3. Cancer Med. 2023. PMID: 35666040 Free PMC article.
Primary hepatic neuroendocrine tumor: A case report.
Morishita A, Yoneyama H, Nomura T, Sakamoto T, Fujita K, Tani J, Miyoshi H, Haba R, Masaki T. Morishita A, et al. Among authors: tani j. Mol Clin Oncol. 2016 Jun;4(6):954-956. doi: 10.3892/mco.2016.822. Epub 2016 Mar 17. Mol Clin Oncol. 2016. PMID: 27284429 Free PMC article.
MicroRNA profiles in various hepatocellular carcinoma cell lines.
Morishita A, Iwama H, Fujihara S, Sakamoto T, Fujita K, Tani J, Miyoshi H, Yoneyama H, Himoto T, Masaki T. Morishita A, et al. Among authors: tani j. Oncol Lett. 2016 Sep;12(3):1687-1692. doi: 10.3892/ol.2016.4853. Epub 2016 Jul 13. Oncol Lett. 2016. PMID: 27588118 Free PMC article.
Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs.
Fujita K, Iwama H, Oura K, Tadokoro T, Hirose K, Watanabe M, Sakamoto T, Katsura A, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Okano K, Suzuki Y, Himoto T, Masaki T. Fujita K, et al. Among authors: tani j. Int J Mol Med. 2016 Oct;38(4):1135-40. doi: 10.3892/ijmm.2016.2729. Epub 2016 Sep 2. Int J Mol Med. 2016. PMID: 27600587 Free PMC article.
Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Takaguchi K, Tsuji K, Itobayashi E, Takizawa D, Hirooka M, Koizumi Y, Ochi H, Joko K, Kisaka Y, Shimizu Y, Tajiri K, Tani J, Taniguchi T, Toshimori A, Fujioka S; Real-Life Practice Experts For Hepatocellular Carcinoma (HCC) (RELPEC) Study Group and The HCC 48 Group (HCC experts from 48 clinics). Hiraoka A, et al. Among authors: tani j. Mol Clin Oncol. 2017 Apr;6(4):455-461. doi: 10.3892/mco.2017.1192. Epub 2017 Mar 10. Mol Clin Oncol. 2017. PMID: 28413650 Free PMC article.
Galectin‑9 ameliorates fulminant liver injury.
Tadokoro T, Morishita A, Sakamoto T, Fujihara S, Fujita K, Mimura S, Oura K, Nomura T, Tani J, Yoneyama H, Iwama H, Himoto T, Niki T, Hirashima M, Masaki T. Tadokoro T, et al. Among authors: tani j. Mol Med Rep. 2017 Jul;16(1):36-42. doi: 10.3892/mmr.2017.6606. Epub 2017 May 18. Mol Med Rep. 2017. PMID: 28534962 Free PMC article.
349 results